Edwards steams ahead of TAVR rival Medtronic with Sapien 3 US approval
This article was originally published in Clinica
Executive Summary
The US FDA has approved Sapien 3, Edwards Lifesciences’ third-generation balloon-expandable transcatheter aortic valve for high risk and inoperable aortic stenosis patients, around three months earlier than the company previously projected.